SOLICITATION NOTICE
A -- Sythesis and Distribution of Drugs of Abuse and Related Compounds
- Notice Date
- 9/18/2007
- Notice Type
- Solicitation Notice
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6101 Executive Boulevard Room 260 - MSC 8402, Bethesda, MD, 20892, UNITED STATES
- ZIP Code
- 20892
- Solicitation Number
- N01DA-8-7763
- Response Due
- 11/19/2007
- Archive Date
- 12/4/2007
- Point of Contact
- Brian O'Laughlin, Contract Specialist, NIDA R&D Contracts Management Branch, Phone (301) 443-6677, Fax (301) 443-7595, - Craig Sager, Contracting Officer, NIDA/NIH, Phone (301) 443-6677, Fax (301) 443-7595,
- E-Mail Address
-
bo50d@nih.gov, cs591t@nih.gov
- Description
- The National Institute on Drug Abuse is soliciting proposals from qualified organizations having the capability to acquire and synthesize labeled and unlabeled drugs of abuse and other chemical compounds including opioid and related neuropeptides. Qualified organizations must also be able to check the stability and purity of the compounds, maintain and store the compound inventory under secure conditions, and distribute the compounds to research investigators as directed by the NIDA Project Officer. Qualified organizations must have the proper facilities, equipment and experience to complete the above-described tasks. As some of the compounds may be scheduled under the Controlled Substances Act, demonstration of proper DEA registration and adequate security is mandatory. In order to handle substances under the Controlled Substances Act of 1970, it is mandatory that offerors possess a DEA Research Registration for Schedules II to V and demonstrate the capability to obtain a DEA registration for Schedule I controlled substances. It is anticipated that one cost reimbursement, completion type contract will be awarded for a period of five years with additional annual option quantities. Release of this solicitation is anticipated on or about October 4, 2007 with a closing date of approxamately November 19, 2007. Award of this contract is anticipated on or about March 13, 2008. All responsible sources may submit a proposal which shall be considered by the agency. See Note 26. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (18-SEP-2007); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link to FedBizOpps document.
(http://www.fbo.gov/spg/HHS/NIH/NIDA-01/N01DA-8-7763/listing.html)
- Place of Performance
- Address: National Institute on Drug Abuse, NIH NIDA R&D Contracts Management Branch 6101 Executive Boulevard, Room 260 Bethesda, Maryland 20892-8402
- Zip Code: 20892
- Country: UNITED STATES
- Zip Code: 20892
- Record
- SN01410421-F 20070920/070919144159 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |